GW Seeing Traction With Epidiolex In The USA

MJ Biz report

It has seen brisk sales and new patient enrollments since the drug’s launch last November.

The company said Epidiolex sales were $68.4 million for the quarter that ended in June.

It also reported Epidiolex has been used by more than 12,000 patients coming from about 2,500 physicians since its launch

Full story

‘Pent-up demand’ for FDA-approved cannabis drug boosts UK maker


Primary Sponsor

Karma Koala Podcast

Top Marijuana Blog